Pharmaceutical companies minimized the international clinical tests of preparations to Russian Federation

The foreign pharmaceutical companies almost ceased to get permissions to carrying out to Russian Federation the international multicenter clinical trials of new original preparations. In the first half of 2023 of such permissions it was given out only seven, and one — the Russian JOINT-STOCK COMPANY "BIOKAD" For the first half of 2023 Minzdrav gave out seven permissions to the international multicenter clinical tests of drugs to the foreign companies and one — the Russian JOINT-STOCK COMPANY "BIOKAD". About it writes newspaper "Kommersant" with reference to AOKI which calculations the newspaper examined...